We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current KRYS market cap is 4.77B. The company's latest EPS is USD 0.3864 and P/E is 437.11.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 8.56M | 42.14M | 45.25M |
Operating Income | -48.82M | -38.05M | -25.99M | 3.14M | -6.68M |
Net Income | -45.3M | -33.21M | 80.75M | 8.69M | 932k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 50.7M |
Operating Income | -22.08M | -33M | -68.28M | -145.2M | -109.73M |
Net Income | -19.09M | -32.17M | -69.57M | -139.98M | 10.93M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 531.85M | 684.03M | 790.35M | 818.36M | 853.3M |
Total Liabilities | 42.28M | 30.91M | 34.4M | 39.71M | 54.05M |
Total Equity | 489.57M | 653.11M | 755.95M | 778.64M | 799.24M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 209.02M | 310.84M | 626.3M | 558.45M | 818.36M |
Total Liabilities | 6.11M | 18.76M | 32.72M | 36.22M | 39.71M |
Total Equity | 202.91M | 292.08M | 593.58M | 522.23M | 778.64M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.16M | -60.35M | -81.57M | -88.8M | 15.89M |
Investing | 3.56M | -12.39M | 92.8M | 82.64M | -25.98M |
Financing | 1.47M | 186.74M | 200.13M | 202.75M | 10.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -18.71M | -26.08M | -47.94M | -100.57M | -88.8M |
Investing | -4.97M | -11.18M | -226.77M | -114.08M | 82.64M |
Financing | 107.53M | 118.02M | 347.69M | 35.35M | 202.75M |
Market Cap | 4.77B |
Price to Earnings Ratio | 437.11 |
Price to Sales Ratio | 94.25 |
Price to Cash Ratio | 13.34 |
Price to Book Ratio | 6.14 |
Dividend Yield | - |
Shares Outstanding | 28.29M |
Average Volume (1 week) | 208.55k |
Average Volume (1 Month) | 267.92k |
52 Week Change | 43.86% |
52 Week High | 189.97 |
52 Week Low | 93.95 |
Spread (Intraday) | 0.43 (0.25%) |
Company Name | Krystal Biotech Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.krystalbio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions